Literature DB >> 22876148

Liver transplantation for symptomatic liver metastases of neuroendocrine tumours.

G Chan1, W Kocha, R Reid, A Taqi, W Wall, D Quan.   

Abstract

Numerous reports have demonstrated that liver transplantation for neuroendocrine tumour metastasis is feasible. However, perioperative risks and long-term recurrences remain significant concerns. When liver transplantation is combined with extensive intestinal or pancreatic resection, the risk is particularly high.We report our institutional experience of liver transplantations performed for liver metastases secondary to neuroendocrine tumours, and in combination with a review of the literature, we propose a set of selection criteria. The key points include unresectable hepatic metastases of neuroendocrine origin, absence of extrahepatic metastases, symptomatic disease that is refractory to medical therapy, a Ki-67 level less than 2%, previous resection of the primary disease, and previous therapy for metastatic neuroendocrine tumour.In our experience, the patient in the first case had, post-transplantation, rapid disease progression because of an unidentified primary, and patient in the second case had primary non-function of the liver graft, requiring urgent re-transplantation. More recently, two liver transplantations were successfully performed. The indications were, in the first case, refractory hormonal secretion and, in the other, secondary biliary cirrhosis attributable to hepatic artery therapy with tumour in situ. Subclinical and stable recurrent disease has been detected by scintigraphy in the mesentery and lumbar spine in the former patient. A mesenteric recurrence developed in the latter patient 2 years post transplantation and was subsequently completely resected. At 4 and 5 years post transplantation, both patients are symptom-free.Recurrence after transplantation remains a significant concern, even with careful patient selection, but recurrences may remain indolent. If recurrences are progressive, they may still be amenable to additional medical or surgical therapy. A national or international consensus between oncologists and transplant specialists regarding the indications for liver transplantation is vital, because future progress will depend on careful patient selection and prospective study.

Entities:  

Keywords:  Liver transplantation; liver metastases; neuroendocrine tumour

Year:  2012        PMID: 22876148      PMCID: PMC3410831          DOI: 10.3747/co.19.950

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  15 in total

1.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

2.  Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.

Authors:  Jens Rosenau; Matthias J Bahr; Reinhard von Wasielewski; Michael Mengel; Hartmut H J Schmidt; Björn Nashan; Hauke Lang; Jürgen Klempnauer; Michael P Manns; Klaus H W Boeker
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

Review 3.  Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis.

Authors:  Zoltan Máthé; Evangelos Tagkalos; Andreas Paul; Ernesto P Molmenti; László Kóbori; Ioannis Fouzas; Susanne Beckebaum; Georgios C Sotiropoulos
Journal:  Transplantation       Date:  2011-03-15       Impact factor: 4.939

4.  Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.

Authors:  Roberto Gedaly; Michael F Daily; Daniel Davenport; Patrick P McHugh; Alvaro Koch; Paul Angulo; Jonathan C Hundley
Journal:  Arch Surg       Date:  2011-08

5.  Everolimus for advanced pancreatic neuroendocrine tumors.

Authors:  James C Yao; Manisha H Shah; Tetsuhide Ito; Catherine Lombard Bohas; Edward M Wolin; Eric Van Cutsem; Timothy J Hobday; Takuji Okusaka; Jaume Capdevila; Elisabeth G E de Vries; Paola Tomassetti; Marianne E Pavel; Sakina Hoosen; Tomas Haas; Jeremie Lincy; David Lebwohl; Kjell Öberg
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

Review 6.  Liver transplantation for metastatic neuroendocrine tumors.

Authors:  H Lang; K J Oldhafer; A Weimann; H J Schlitt; G F Scheumann; P Flemming; B Ringe; R Pichlmayr
Journal:  Ann Surg       Date:  1997-04       Impact factor: 12.969

Review 7.  Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients.

Authors:  T Lehnert
Journal:  Transplantation       Date:  1998-11-27       Impact factor: 4.939

8.  Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.

Authors:  Frederike G I van Vilsteren; Edwina S Baskin-Bey; David M Nagorney; Schuyler O Sanderson; Walter K Kremers; Charles B Rosen; Gregory J Gores; Timothy J Hobday
Journal:  Liver Transpl       Date:  2006-03       Impact factor: 5.799

9.  Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report.

Authors:  Y P Le Treut; E Grégoire; J Belghiti; O Boillot; O Soubrane; G Mantion; D Cherqui; D Castaing; P Ruszniewski; P Wolf; F Paye; E Salame; F Muscari; F R Pruvot; J Baulieux
Journal:  Am J Transplant       Date:  2008-04-29       Impact factor: 8.086

10.  Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience.

Authors:  N Thao T Nguyen; Theresa R Harring; John A Goss; Christine A O'Mahony
Journal:  Int J Hepatol       Date:  2011-12-29
View more
  3 in total

1.  Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables.

Authors:  Linda S Sher; David M Levi; Julie S Wecsler; Mary Lo; Lydia M Petrovic; Susan Groshen; Lingyun Ji; Teresa Diago Uso; A Joseph Tector; Ann S Hamilton; J Wallis Marsh; Myron E Schwartz
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

Review 2.  Liver transplantation in patients with neuroendocrine tumors: a case series and literature review.

Authors:  Diana Ilić; Nino Kunac; Tina Borčić; Petra Dinjar Kujundžić; Zrinka Mišetić Dolić; Nikola Sobočan; Miloš Lalovac; Maja Mijić; Goran Međimurec; Branislav Kocman; Ivana Mikolašević; Tajana Filipec Kanižaj
Journal:  Croat Med J       Date:  2021-02-28       Impact factor: 1.351

3.  Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies.

Authors:  Stefano Bacchetti; Serena Bertozzi; Ambrogio P Londero; Alessandro Uzzau; Enrico Maria Pasqual
Journal:  Int J Hepatol       Date:  2013-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.